The prognosis with large hepatocellular carcinomas is poor, and only p
alliative treatment is available. Small tumors are amenable to several
modes of treatment, including liver transplantation, resection, or al
cohol injection, with acceptable 5-year survival rates. Although the v
alue of screening for hepatocellular carcinoma has yet to be shown, th
ese data, coupled with the recognition of at-risk groups and useful di
agnostic techniques, might encourage the clinician to screen at-risk p
atients in the clinic. New imaging techniques such as ultrasonographic
angiography enhanced with CO2 microbubbles, or color Doppler ultrasou
nd, may clarify the intratumoral blood flow of small tumors.